Ascelia Pharma AB
STO:ACE
Income Statement
Earnings Waterfall
Ascelia Pharma AB
Income Statement
Ascelia Pharma AB
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(25)
|
(26)
|
(24)
|
(31)
|
(37)
|
(47)
|
(37)
|
(72)
|
(86)
|
(88)
|
(93)
|
(107)
|
(110)
|
(127)
|
(138)
|
(137)
|
(137)
|
(134)
|
(147)
|
(151)
|
(160)
|
(152)
|
(111)
|
(91)
|
(60)
|
(57)
|
(68)
|
(71)
|
(83)
|
(81)
|
(74)
|
|
| Selling, General & Administrative |
(16)
|
(15)
|
(13)
|
(15)
|
(14)
|
(17)
|
(8)
|
(18)
|
(18)
|
(19)
|
(18)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(16)
|
(15)
|
(15)
|
(15)
|
(18)
|
(19)
|
(20)
|
(22)
|
(21)
|
(20)
|
(18)
|
(16)
|
(16)
|
(17)
|
(17)
|
|
| Research & Development |
(9)
|
(11)
|
(12)
|
(16)
|
(23)
|
(30)
|
(27)
|
(51)
|
(58)
|
(60)
|
(65)
|
(58)
|
(66)
|
(80)
|
(108)
|
(103)
|
(104)
|
(102)
|
(118)
|
(123)
|
(127)
|
(118)
|
(81)
|
(62)
|
(39)
|
(39)
|
(51)
|
(56)
|
(67)
|
(64)
|
(57)
|
|
| Other Operating Expenses |
1
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(10)
|
(10)
|
(10)
|
(32)
|
(28)
|
(30)
|
(13)
|
(16)
|
(18)
|
(16)
|
(14)
|
(13)
|
(15)
|
(15)
|
(10)
|
(7)
|
(1)
|
2
|
1
|
0
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(25)
N/A
|
(26)
-5%
|
(24)
+8%
|
(31)
-31%
|
(37)
-20%
|
(47)
-27%
|
(37)
+22%
|
(72)
-95%
|
(86)
-20%
|
(88)
-3%
|
(93)
-6%
|
(107)
-14%
|
(110)
-3%
|
(127)
-15%
|
(138)
-9%
|
(137)
+1%
|
(137)
0%
|
(134)
+2%
|
(147)
-10%
|
(151)
-3%
|
(160)
-6%
|
(152)
+5%
|
(111)
+27%
|
(91)
+18%
|
(60)
+34%
|
(57)
+6%
|
(68)
-19%
|
(71)
-5%
|
(83)
-16%
|
(81)
+3%
|
(74)
+8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
2
|
1
|
(3)
|
(2)
|
12
|
(6)
|
(4)
|
(3)
|
8
|
7
|
17
|
18
|
14
|
11
|
3
|
(0)
|
1
|
2
|
(1)
|
(6)
|
(3)
|
(14)
|
(12)
|
(9)
|
(2)
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(5)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(9)
|
0
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(25)
N/A
|
(26)
-5%
|
(24)
+8%
|
(31)
-31%
|
(38)
-21%
|
(46)
-24%
|
(40)
+14%
|
(71)
-79%
|
(89)
-24%
|
(91)
-2%
|
(100)
-10%
|
(112)
-13%
|
(114)
-2%
|
(129)
-13%
|
(130)
0%
|
(130)
-1%
|
(120)
+8%
|
(116)
+3%
|
(133)
-15%
|
(140)
-5%
|
(157)
-12%
|
(152)
+3%
|
(110)
+28%
|
(89)
+19%
|
(62)
+30%
|
(62)
-1%
|
(80)
-28%
|
(85)
-6%
|
(95)
-12%
|
(89)
+6%
|
(77)
+14%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
4
|
4
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(24)
|
(25)
|
(23)
|
(30)
|
(37)
|
(46)
|
(40)
|
(71)
|
(88)
|
(90)
|
(99)
|
(111)
|
(113)
|
(127)
|
(126)
|
(126)
|
(115)
|
(113)
|
(131)
|
(139)
|
(157)
|
(152)
|
(109)
|
(89)
|
(62)
|
(62)
|
(80)
|
(85)
|
(95)
|
(89)
|
(76)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(24)
N/A
|
(25)
-4%
|
(23)
+8%
|
(30)
-31%
|
(37)
-22%
|
(46)
-24%
|
(40)
+13%
|
(71)
-78%
|
(88)
-24%
|
(90)
-2%
|
(99)
-10%
|
(111)
-12%
|
(113)
-2%
|
(127)
-12%
|
(126)
+1%
|
(126)
0%
|
(115)
+8%
|
(113)
+2%
|
(131)
-16%
|
(139)
-6%
|
(157)
-13%
|
(152)
+3%
|
(109)
+28%
|
(89)
+19%
|
(62)
+30%
|
(62)
-1%
|
(80)
-28%
|
(85)
-6%
|
(95)
-11%
|
(89)
+6%
|
(76)
+14%
|
|
| EPS (Diluted) |
-1.08
N/A
|
-1.13
-5%
|
-1.04
+8%
|
-1.79
-72%
|
-2.16
-21%
|
-1.96
+9%
|
-1.7
+13%
|
-3
-76%
|
-3.66
-22%
|
-3.14
+14%
|
-3.76
-20%
|
-3.85
-2%
|
-3.33
+14%
|
-3.66
-10%
|
-2.64
+28%
|
-3.64
-38%
|
-3.42
+6%
|
-3.35
+2%
|
-2.61
+22%
|
-3.99
-53%
|
-4.65
-17%
|
-3.11
+33%
|
-2.24
+28%
|
-1.81
+19%
|
-1.26
+30%
|
-0.83
+34%
|
-1.48
-78%
|
-0.88
+41%
|
-0.83
+6%
|
-0.75
+10%
|
-0.67
+11%
|
|